COUNTERFEIT DRUGS REMAIN A SUPPLY CHAIN RISK IN EMERGING MARKETS
Counterfeit drugs gained notoriety in the mid-1980s with the illegal reproduction of prescription products to treat baldness and obesity. More than 25 years later, falsified drugs are still a persistent threat—with products ranging from those in high demand to those that are intended to save lives.
| Have Your Say Rate this feature and give us your feedback in the comments section below |